Free Trial

Scilex (SCLX) News Today

Scilex logo
$4.43 +0.37 (+9.11%)
As of 04:00 PM Eastern
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Reaches New 1-Year Low - Should You Sell?
Scilex (NASDAQ:SCLX) Sets New 52-Week Low - Here's Why
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Trading Down 12.2% - Here's What Happened
Scilex (NASDAQ:SCLX) Stock Price Down 12.2% - Should You Sell?
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Sees Large Volume Increase - Here's Why
Scilex (NASDAQ:SCLX) Sees Large Volume Increase - What's Next?
Scilex treatment of pericarditis granted FDA orphan designation
Scilex confirms FDA awards orphan drug designation for colchicine
Scilex (NASDAQ:SCLX) Given "Hold" Rating at D. Boral Capital
Scilex announces 1-for-35 reverse stock split
Scilex Holding stock logo
D. Boral Capital Lowers Scilex (NASDAQ:SCLX) Price Target to $18.00
D. Boral Capital decreased their price target on Scilex from $22.00 to $18.00 and set a "buy" rating for the company in a report on Wednesday.
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Stock Price Up 1.8% - Here's What Happened
Scilex (NASDAQ:SCLX) Shares Up 1.8% - Still a Buy?
Scilex Holding stock logo
Scilex (SCLX) Projected to Post Earnings on Monday
Scilex (NASDAQ:SCLX) will be releasing earnings before the market opens on Monday, March 10, Financial Modeling Prep reports.
Scilex Holding stock logo
Short Interest in Scilex Holding (NASDAQ:SCLX) Expands By 40.6%
Scilex Holding (NASDAQ:SCLX - Get Free Report) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 6,100,000 shares, an increase of 40.6% from the January 31st total of 4,340,000 shares. Approximately 3.4% of the company's stock are sold short. Based on an average daily volume of 1,430,000 shares, the short-interest ratio is currently 4.3 days.
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Receives Buy Rating from D. Boral Capital
D. Boral Capital reiterated a "buy" rating and issued a $22.00 target price on shares of Scilex in a research report on Friday.
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Stock Price Down 1.7% - Time to Sell?
Scilex (NASDAQ:SCLX) Shares Down 1.7% - What's Next?
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Coverage Initiated at D. Boral Capital
D. Boral Capital began coverage on Scilex in a research report on Monday. They issued a "buy" rating and a $22.00 price target for the company.
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Coverage Initiated by Analysts at D. Boral Capital
D. Boral Capital initiated coverage on Scilex in a research note on Monday. They issued a "buy" rating and a $22.00 price target on the stock.
Scilex regains compliance with Nasdaq listing rules
Scilex to file SNDA with FDA for ELYXYB
Scilex Holding stock logo
Scilex (NASDAQ:SCLX) Announces Earnings Results
Scilex (NASDAQ:SCLX - Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.18) earnings per share (EPS) for the quarter.
Scilex amends license agreement with Romeg Therapeutics
Scilex announces change in record date for dividend of preferred stock
Scilex Holding stock logo
Scilex Holding (NASDAQ:SCLX) Short Interest Down 14.0% in December
Scilex Holding (NASDAQ:SCLX - Get Free Report) saw a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 5,280,000 shares, a decrease of 14.0% from the November 30th total of 6,140,000 shares. Approximately 3.3% of the shares of the stock are short sold. Based on an average daily volume of 2,070,000 shares, the short-interest ratio is presently 2.6 days.
Scilex Holding stock logo
Jaisim Shah Purchases 30,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock
Scilex Holding (NASDAQ:SCLX - Get Free Report) insider Jaisim Shah bought 30,000 shares of the stock in a transaction on Wednesday, December 18th. The shares were acquired at an average cost of $0.46 per share, for a total transaction of $13,800.00. Following the purchase, the insider now owns 139,333 shares in the company, valued at approximately $64,093.18. This represents a 27.44 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Get Scilex News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter.

SCLX Media Mentions By Week

SCLX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SCLX
News Sentiment

0.23

0.72

Average
Medical
News Sentiment

SCLX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SCLX Articles
This Week

3

2

SCLX Articles
Average Week

Get Scilex News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SCLX) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners